tiprankstipranks
Trending News
More News >
Eris Lifesciences Ltd (IN:ERIS)
:ERIS
India Market

Eris Lifesciences Ltd (ERIS) Financial Statements

Compare
0 Followers

Eris Lifesciences Ltd Financial Overview

Eris Lifesciences Ltd's market cap is currently ₹252.79B. The company's EPS TTM is ₹6.9; its P/E ratio is 71.80; and it has a dividend yield of 0.41%. Eris Lifesciences Ltd is scheduled to report earnings on May 19, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 28.79B₹ 19.91B₹ 16.62B₹ 13.26B₹ 11.93B
Gross Profit₹ 13.59B₹ 9.95B₹ 13.09B₹ 10.65B₹ 9.51B
Operating Income₹ 16.60B₹ 4.95B₹ 4.22B₹ 4.25B₹ 3.88B
EBITDA₹ 10.17B₹ 6.99B₹ 5.48B₹ 5.11B₹ 4.39B
Net Income₹ 3.52B₹ 3.92B₹ 3.82B₹ 4.06B₹ 3.55B
Balance Sheet
Cash & Short-Term Investments₹ 2.28B₹ 13.39B₹ 892.43M₹ 1.77B₹ 522.69M
Total Assets₹ 70.33B₹ 70.49B₹ 36.67B₹ 22.72B₹ 18.35B
Total Debt₹ 24.78B₹ 27.81B₹ 8.77B₹ 844.07M₹ 67.77M
Net Debt₹ 22.55B₹ 26.87B₹ 8.21B₹ 336.13M₹ -300.93M
Total Liabilities₹ 37.61B₹ 38.27B₹ 14.47B₹ 3.64B₹ 2.58B
Stockholders' Equity₹ 28.54B₹ 25.86B₹ 21.96B₹ 19.08B₹ 15.76B
Cash Flow
Free Cash Flow₹ 9.10B₹ 3.57B₹ -5.50B₹ 2.57B₹ 3.50B
Operating Cash Flow₹ 10.65B₹ 4.86B₹ 2.92B₹ 3.78B₹ 3.75B
Investing Cash Flow₹ -799.70M₹ -18.55B₹ -9.82B₹ -3.20B₹ -3.23B
Financing Cash Flow₹ -8.81B₹ 13.80B₹ 6.88B₹ -446.99M₹ -823.95M
Currency in INR

Eris Lifesciences Ltd Earnings and Revenue History

Eris Lifesciences Ltd Debt to Assets

Eris Lifesciences Ltd Cash Flow

Eris Lifesciences Ltd Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis